Anadroxyl 50 mg

Anadroxyl 50 mg contains oxymetholone, which is FDA-approved for treating anemias caused by deficient red cell production, including aplastic anemia and anemias related to myelotoxic drugs. In non-medical bodybuilding contexts, oxymetholone is commonly referenced for rapid mass and strength gains during bulking phases, though such use falls outside approved medical indications.

In medical settings, oxymetholone is typically dosed once daily or in divided doses based on body weight and clinical response. Because the compound has a short half-life of approximately 8–9 hours, non-medical use often involves splitting the daily dose into two or three administrations to maintain more stable blood levels.

Oxymetholone suppresses endogenous testosterone production, so in non-medical bodybuilding contexts, post-cycle therapy is commonly recommended after any cycle involving this compound. Agents such as Clomixyl 50 mg or Nolvaxyl 20 mg are commonly referenced for this purpose.

Oxymetholone is an anabolic steroid that promotes nitrogen retention, protein synthesis, and red blood cell production. It increases erythropoietin production and erythropoiesis in patients with anemias due to bone marrow failure. In non-medical contexts, these effects contribute to increased muscle mass, strength, and appetite, though non-medical use falls outside approved indications.

In medical settings for anemia, response to oxymetholone is not immediate and a minimum trial of three to six months is typically recommended. In non-medical bodybuilding contexts, users often report noticeable strength and weight gains within the first two weeks, though individual response varies.

There is no single oral steroid that is universally best. Oxymetholone is among the most potent oral anabolics for mass and strength, but it is also associated with significant hepatotoxicity and side effects. Other orals such as Dianoxyl 10 and Stanoxyl 10 have different potency, side effect, and aromatization profiles. The appropriate compound depends on individual goals and risk tolerance.

Both oxymetholone and methandienone are potent 17-alpha-alkylated oral anabolic steroids commonly referenced for bulking. Methandienone is aromatizable, meaning it converts to estrogen and can cause estrogenic side effects through that pathway. Oxymetholone is not directly aromatized but is still associated with estrogenic effects through less understood mechanisms. Oxymetholone is generally considered more hepatotoxic.

Oxymetholone and stanozolol are both oral 17-alpha-alkylated anabolic steroids, but they have different profiles. Oxymetholone is primarily used for bulking and mass gain, with significant water retention and hepatotoxicity. Stanozolol is more commonly referenced for cutting phases, as it does not aromatize and is associated with leaner, drier gains. Both carry hepatotoxic risk.

In medical settings, oxymetholone dosing is individualized by body weight, typically ranging from 1–5 mg/kg per day. For a 100 kg patient, 50 mg would represent 0.5 mg/kg, which is below the usual effective medical range. In non-medical bodybuilding contexts, 50 mg per day is often referenced as a starting point, with experienced users sometimes using higher doses. Any use carries hepatotoxic risk.

Anadroxyl 50 mg is labeled at 50 mg of oxymetholone per tablet. It is supplied in packs of 50 tablets, giving 2,500 mg of total labeled oxymetholone content per pack.

Yes, gynecomastia has been reported in non-medical users of oxymetholone, including in a published case report of an amateur bodybuilder who developed painful gynecomastia after using oxymetholone. Although oxymetholone is not directly aromatized to estrogen, the mechanism behind this effect is not fully understood. Management in non-medical contexts sometimes involves aromatase inhibitors or SERMs, though medical guidance is advised.

Laboratory testing information for Anadroxyl 50 mg is not currently available in this product listing. Kalpa Pharmaceuticals products are manufactured under pharmaceutical-grade conditions, but independent lab reports are not published for this specific product at this time.